Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)

Filter results: >>>>
Cell line Drug name Experimental replicate Timepoint Drug concentration Live cell count Average live cell count, DMSO control Average live cell count (time = 0) Log10(drug concentration) GR value Relative cell count (treatment versus DMSO) Cell doublings (DMSO control) Experiment name
BT-549 Dactolisib 3 72
1.0
1156.3 4098.5 1175.8
0.0
-0.009 0.282 1.801
BT549 BEZ235 0 3 72
Hs 578T Omipalisib 2 72
0.1
1004.5 3550.3 624.7
-1.0
0.209 0.283 2.507
Hs578T GSK458 2
BT-549 Dactolisib 3 72
3.2
1161.8 4098.5 1175.8
0.505
-0.007 0.283 1.801
BT549 BEZ235 0 3 72
Hs 578T Omipalisib 3 72
0.1
1188.5 4175.0 571.3
-1.0
0.291 0.285 2.869
Hs578T GSK458 3
Hs 578T AZD8055 1 72
3.2
1005.8 3514.5 873.1
0.505
0.073 0.286 2.009
Hs578T AZD8055 1
Hs 578T Dactolisib 3 72
0.1
1169.3 4081.0 571.3
-1.0
0.287 0.287 2.837
Hs578T BEZ235 3
BT-549 Torin1 2 72
3.2
1320.5 4603.3 1249.6
0.505
0.030 0.287 1.881
BT549 Torin1 0 2 72
BT-549 Omipalisib 2 72
0.1
1429.3 4963.8 1249.6
-1.0
0.070 0.288 1.990
BT549 GSK458 0 2 72
BT-20 Torin1 3 72
0.1
1001.5 3483.3 586.9
-1.0
0.231 0.288 2.569
BT20 Torin1 0 3
BT-549 Torin2 1 72
0.32
1528.8 5306.0 1554.9
-0.495
-0.010 0.288 1.771
BT549 Torin2 0 1 72
BT-20 Buparlisib 2 72
1.0
986.5 3408.8 1018.6
0.0
-0.018 0.289 1.743
BT20 BKM120 0 2
Hs 578T WYE-125132 1 72
3.2
1021.0 3529.8 873.1
0.505
0.081 0.289 2.015
Hs578T WYE125132 1
HCC38 Omipalisib 3 72
0.32
933.8 3215.3 1180.5
-0.495
-0.150 0.290 1.446
HCC38 GSK458 0 3 72
Hs 578T Dactolisib 3 72
0.032
1181.8 4081.0 571.3
-1.49
0.292 0.290 2.837
Hs578T BEZ235 3
HCC38 Dactolisib 3 72
1.0
951.0 3265.3 1180.5
0.0
-0.137 0.291 1.468
HCC38 BEZ235 0 3 72
HCC70 Torin2 1 72
0.32
957.5 3294.3 1279.8
-0.495
-0.192 0.291 1.364
HCC70 Torin2 0 1 72
BT-20 Torin1 1 72
1.0
1708.3 5863.3 1443.3
0.0
0.087 0.291 2.022
BT20 Torin1 0 1
BT-549 Dactolisib 1 72
1.0
1630.8 5568.8 1554.9
0.0
0.026 0.293 1.840
BT549 BEZ235 0 1 72
HCC1806 Omipalisib 2 72
0.32
3470.8 11840.0 1643.3
-0.495
0.300 0.293 2.849
HCC1806 GSK458 0 2 72
HCC1806 Omipalisib 3 72
0.32
3470.8 11840.0 1273.3
-0.495
0.366 0.293 3.217
HCC1806 GSK458 0 3 72
HCC70 GDC-0980 3 72
3.2
814.0 2773.8 517.3
0.505
0.206 0.293 2.423
HCC70 GDC0980 0 3 72
HCC1806 Omipalisib 1 72
0.32
3470.8 11840.0 1742.8
-0.495
0.283 0.293 2.764
HCC1806 GSK458 0 1 72
BT-549 Dactolisib 2 72
1.0
1361.5 4628.8 1249.6
0.0
0.047 0.294 1.889
BT549 BEZ235 0 2 72
HCC38 Torin1 2 72
1.0
895.5 3034.5 690.5
0.0
0.129 0.295 2.136
HCC38 Torin1 0 2 72
HCC70 Omipalisib 1 72
0.032
968.5 3280.0 1279.8
-1.49
-0.186 0.295 1.358
HCC70 GSK458 0 1 72